Author

M. Spurrell

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

N. Hacohen· 2 shared A. Arazi· 1 shared A. Davidson· 1 shared A. Fava· 1 shared A. L. Tang· 1 shared A. Mehta· 1 shared A. Shih· 1 shared A. Sonny· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

N. Hacohen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intrarenal myeloid subsets associated with kidney injury are comparable in mice and patients with lupus nephritis

P. Hoover, D. J. Lieb, J. Kang, S. Li, M. Peters, C. Raparia, A. Arazi, T. Eisenhaure, S. S. Gurajala, Q. Xiao, R. Mishra, M. Spurrell, R. Menon, M. Kretzler, J. Chen, , A. Davidson

This study identifies conserved myeloid subsets and disease-associated gene expression changes in kidney injury across lupus mouse models and human patients with lupus nephritis.

bioRxiv · Jun 24, 2023 · PreprintImmunology

Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response

J. H. Chen, L. T. Nieman, M. Spurrell, V. Jorgji, P. M. Richieri, K. H. Xu, R. Madhu, M. Parikh, I. Zamora, A. Mehta, C. S. Nabel, S. S. Freeman, J. D. Pirl, C. Lu, C. B. Meador, , N. Hacohen

The paper identifies immune hubs in lung cancer that are associated with better responses to PD-1-blockade immunotherapy and contain stem-like CD8 T cells.

bioRxiv · Apr 4, 2023Immunology